Description
GALVmed is a not-for-profit global alliance of public, private, and government
partners that protects livestock and human lives and livelihoods by making
livestock vaccines, diagnostics, and medicines accessible and affordable in
developing countries where livestock is a lifeline for millions of people.
GALVmed raises awareness about the links between livestock health, economic
development, and human health and supports research and development to
advance innovation in vaccines, pharmaceutical and diagnostic products.
GALVmed focuses on 13 key diseases (broken into four categories: avian,
swine, small ruminant and cattle diseases with some overlap) that are most
relevant to poverty reduction in target areas.
Purpose
GALVmed's mission is to protect livestock and save human lives. GALVmed
seeks to play a major role in poverty reduction and livelihood enhancement
through livestock intervention by 2015, in support of the Millennium
Development Goals (see references in appendices).
http://www.un.org/millenniumgoals/bkgd.shtml
Scope International – Sub-Saharan Africa, Southern Asia and potentially South
America.
Primary Funders
GALVmed is currently funded by the Bill & Melinda Gates Foundation and the
UK Department for International Development (DFID).
Participants & Key Collaborators
Key collaborators include agricultural non-governmental organizations
(NGOs), health and development agencies, pharmaceutical companies,
investors and donors, transnational authorities, governments, regulatory
authorities, civil society organizations, international research institutes,
universities and other research organizations, and most critically the people that
GALVmed aims to benefit
.
Definition of One Health
GALVmed shares their One Health message by highlighting the connection
between livestock and healthy people. 700 million of the world's poorest
people rely on livestock for their survival. Healthier livestock can provide a
pathway out of poverty, enhance food security, and make farming families
healthier.
Monitoring & Evaluation Strategy
GALVmed appointed a Monitoring and Evaluation (M&E) specialist in 2011 to
design an M&E system and to help build the internal capacity to make it work.
Outputs from this work include the production of a monitoring and evaluation
readiness assessment report; reports (including key performance indicators) on
social economic impact and gender and other metrics; a detailed data collection
timeline; and an indicator protocol.
Sources of Information
GALVmed Website: http://galvmed.org/
Contact GALVmed, UK office
